A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease

Innate immune recognition

Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394 · see citing works

Toll-Like Receptors

Takeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143 · see citing works

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591 · see citing works

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030 · see citing works

Toll-like receptors: critical proteins linking innate and acquired immunity

Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777 · see citing works

Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis

Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251 · see citing works

Clinicopathologic study of dextran sulfate sodium experimental acute colitis

Shichijo, K., Matuu, M., Ikeda, Y., Naito, S., Ito, M., & Sekine, I. (1998) · The Japanese Journal of Pharmacology · doi:10.1016/s0021-5198(19)41298-5 · Cited by 1,943 · see citing works

The Immunology of Mucosal Models of Inflammation

Strober, W., Fuss, I. J., & Blumberg, R. S. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064816 · Cited by 1,300 · see citing works

Differential Alteration in Intestinal Epithelial Cell Expression of Toll-Like Receptor 3 (TLR3) and TLR4 in Inflammatory Bowel Disease

Cario, E., & Podolsky, D. K. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.7010-7017.2000 · Cited by 1,245 · see citing works

Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils

Takeda, K., Clausen, B. E., Kaisho, T., Tsujimura, T., Terada, N., Förster, I., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80005-9 · Cited by 1,220 · see citing works

Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

Duchmann, R., Kaiser, I., Hermann, E., Mayet, W.-J., Ewe, K., & BÜSCHENFELDE, K.-H. M. Z. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03836.x · Cited by 938 · see citing works

Decreased Expression of Toll-Like Receptor-4 and MD-2 Correlates with Intestinal Epithelial Cell Protection Against Dysregulated Proinflammatory Gene Expression in Response to Bacterial Lipopolysaccharide

Abreu, M. T., Vora, P., Faure, E., Thomas, L. S., Arnold, E. T., & Arditi, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1609 · Cited by 681 · see citing works

A Novel Model of Inflammatory Bowel Disease: Mice Deficient for the Multiple Drug Resistance Gene, mdr1a, Spontaneously Develop Colitis

Panwala, C. M., Jones, J. C., & Viney, J. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5733 · Cited by 567 · see citing works

Recognition of microbial infection by Toll-like receptors

Kopp, E. B., & Medzhitov, R. M. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00080-3 · Cited by 547 · see citing works

Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation

Hausmann, M., Kießling, S., Mestermann, S., Webb, G. R., Spöttl, T., Andus, T., Schölmerich, J., Herfarth, H. H., Ray, K., Falk, W., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.33662 · Cited by 488 · see citing works

Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation

Poltorak, A. N., Ricciardi‐Castagnoli, P., Citterio, S., & Beutler, B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040565397 · Cited by 430 · see citing works

Lipopolysaccharide Interaction with Cell Surface Toll-like Receptor 4-MD-2

Akashi, S., Saitoh, S.-I., Wakabayashi, Y., Kikuchi, T., Takamura, N., Nagai, Y., Kusumoto, Y., Fukase, K., Kusumoto, S., Adachi, Y., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031076 · Cited by 385 · see citing works

Biologic therapy of inflammatory bowel disease

Sandborn, W. J., & Targan, S. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.33426 · Cited by 344 · see citing works

Intracellular Recognition of Lipopolysaccharide by Toll-like Receptor 4 in Intestinal Epithelial Cells

Hornef, M. W., Normark, B. H., Vandewalle, A., & Normark, S. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022194 · Cited by 330 · see citing works

Intestinal Macrophages Lack CD14 and CD89 and Consequently Are Down-Regulated for LPS- and IgA-Mediated Activities

Smith, P. D., Smythies, L. E., Mosteller‐Barnum, M., Sibley, D. A., Russell, M. W., Merger, M., Sellers, M. T., Orenstein, J. M., Shimada, T., Graham, M. F., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2651 · Cited by 327 · see citing works

Control of adaptive immune responses by Toll-like receptors

Barton, G. M., & Medzhitov, R. M. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00343-6 · Cited by 325 · see citing works

Differential Effects of a Toll-Like Receptor Antagonist on Mycobacterium tuberculosis-Induced Macrophage Responses

Means, T. K., Jones, B. W., Schromm, A. B., Shurtleff, B. A., Smith, J. A., Keane, J., Golenbock, D. T., Vogel, S. N., & Fenton, M. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.4074 · Cited by 269 · see citing works

MD-2 and TLR4 N-Linked Glycosylations Are Important for a Functional Lipopolysaccharide Receptor

Correia, J. D. S., & Ulevitch, R. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109910200 · Cited by 262 · see citing works

Taking toll: lipid A mimetics as adjuvants and immunomodulators

Persing, D. H., Coler, R. N., Lacy, M. J., Johnson, D. A., Baldridge, J. R., Hershberg, R. M., & Reed, S. G. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02426-5 · Cited by 260 · see citing works

Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice

Kobayashi, M., Kweon, M., Kuwata, H., Schreiber, R. D., Kiyono, H., Takeda, K., & Akira, S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17085 · Cited by 251 · see citing works

Therapy of inflammatory bowel disease

Sands, B. E. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70007-2 · Cited by 235 · see citing works

Structure-Activity Relationship of Synthetic Toll-like Receptor 4 Agonists

Stöver, A. G., Correia, J. D. S., Evans, J. T., Cluff, C. W., Elliott, M. W., Jeffery, E. W., Johnson, D. A., Lacy, M. J., Baldridge, J. R., Probst, P., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310760200 · Cited by 159 · see citing works

Activation of Mammalian Toll-like Receptors by Endogenous Agonists

Johnson, G. B., Brunn, G. J., & Platt, J. L. (2003) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v23.i12.20 · Cited by 143 · see citing works

Helicobacter bilis Infection Accelerates and H. hepaticus Infection Delays the Development of Colitis in Multiple Drug Resistance-Deficient (mdr1a−/−) Mice

Maggio‐Price, L., Shows, D. M., Waggie, K. S., Burich, A., Zeng, W., Escobar, S. M., Morrissey, P., & Viney, J. L. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64894-8 · Cited by 135 · see citing works

Autoimmunity and Apoptosis: The Crohn's Connection

Beutler, B. (2001) · Immunity · doi:10.1016/s1074-7613(01)00176-5 · Cited by 118 · see citing works

A Leishmania protein that modulates interleukin (IL)‐12, IL‐10 and tumor necrosis factor‐α production and expression of B7‐1 in human monocyte‐derived antigen‐presenting cells

Probst, P., Skeiky, Y. A. W., Steeves, M., Gervassi, A. L., Grabstein, K. H., & Reed, S. G. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271024 · Cited by 96 · see citing works

Responses to self and non-self intestinal microflora in health and inflammatory bowel disease

Duchmann, R., Neurath, M. F., & Büschenfelde, K. H. M. Z. (1997) · Research in Immunology · doi:10.1016/s0923-2494(98)80154-5 · Cited by 87 · see citing works

Synthesis and biological evaluation of a new class of vaccine adjuvants: aminoalkyl glucosaminide 4-phosphates (AGPs)

Johnson, D. A., Sowell, C. G., Johnson, C. L., Livesay, M. T., Keegan, D. S., Rhodes, M. J., Ulrich, J. T., Ward, J. R., Cantrell, J. L., & Brookshire, V. G. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00374-1 · Cited by 67 · see citing works

E5531, a synthetic non‐toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharide

Kawata, T., Bristol, J. R., Rossignol, D. P., Rose, J., Kobayashi, S., Yokohama, H., Ishibashi, A., Christ, W. J., Katayama, K., Yamatsu, I., et al. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702596 · Cited by 62 · see citing works

Probiotics in inflamatory bowel disease

Shanahan, F. (2001) · Gut · doi:10.1136/gut.48.5.609 · Cited by 60 · see citing works

The role of the Lps gene in experimental ulcerative colitis in mice

Lange, S., Delbro, D. S., Jennische, E., & Mattsby‐Baltzer, I. (1996) · Apmis · doi:10.1111/j.1699-0463.1996.tb04948.x · Cited by 46 · see citing works

The C3H/HeJBir Mouse Model: A High Susceptibility Phenotype for Colitis

Elson, C. O., Cong, Y., & Sundberg, J. P. (2000) · International Reviews of Immunology · doi:10.3109/08830180009048390 · Cited by 34 · see citing works

Structural features that influence the ability of lipid A and its analogs to abolish expression of suppressor T cell activity

Baker, P. J., Hrabă, T., Taylor, C. E., Myers, K. R., Takayama, K., Qureshi, N., Stuetz, P. L., Kusumoto, S., & Hasegawa, A. (1992) · Infection and Immunity · doi:10.1128/iai.60.7.2694-2701.1992 · Cited by 26 · see citing works

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559 · see citing works

Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function

Abreu, M. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2707 · Cited by 1,288 · see citing works

Regulation of Intestinal Barrier Function by Microbial Metabolites

Ghosh, S., Whitley, C. S., Haribabu, B., & Jala, V. R. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.02.007 · Cited by 835 · see citing works

The Gut Microbiome, Kidney Disease, and Targeted Interventions

Ramezani, A., & Raj, D. S. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013080905 · Cited by 753 · see citing works

Decoding Toll-like receptors: Recent insights and perspectives in innate immunity

Kawai, T., Ikegawa, M., Ori, D., & Akira, S. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.004 · Cited by 559 · see citing works

Gut Microbiota, Lipopolysaccharides, and Innate Immunity in the Pathogenesis of Obesity and Cardiovascular Risk

Manco, M., Putignani, L., & Bottazzo, G. F. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0030 · Cited by 479 · see citing works

TLR-dependent T cell activation in autoimmunity

Mills, K. H. G. (2011) · Nature reviews. Immunology · doi:10.1038/nri3095 · Cited by 439 · see citing works

The Roles of Bacteria and TLR4 in Rat and Murine Models of Necrotizing Enterocolitis

Jilling, T., Simon, D., Lu, J. N., Meng, F. J., Li, D., Schy, R., Thomson, R. B., Soliman, A., Arditi, M., & Caplan, M. S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3273 · Cited by 395 · see citing works

A Novel Cyclohexene Derivative, Ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), Selectively Inhibits Toll-Like Receptor 4-Mediated Cytokine Production through Suppression of Intracellular Signaling

Ii, M., Matsunaga, N., Hazeki, K., Nakamura, K., Takashima, K., Seya, T., Hazeki, O., Kitazaki, T., & Iizawa, Y. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.019695 · Cited by 378 · see citing works

Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease

Violi, F., Cammisotto, V., Bartimoccia, S., Pignatelli, P., Carnevale, R., & Nocella, C. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00737-2 · Cited by 384 · see citing works

Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence

Ibiza, S., García-Cassani, B., Ribeiro, H., Carvalho, T., Almeida, L., Marques, R., Misic, A. M., Bartow‐McKenney, C., Larson, D. M., Pavan, W. J., et al. (2016) · Nature · doi:10.1038/nature18644 · Cited by 362 · see citing works

Toll-like receptors in inflammatory bowel diseases: A decade later

Cario, E. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21282 · Cited by 339 · see citing works

The Yin and Yang of Toll-like receptors in cancer

Pradère, J., Dapito, D. H., & Schwabe, R. F. (2013) · Oncogene · doi:10.1038/onc.2013.302 · Cited by 332 · see citing works

Toll-like receptors as targets in chronic liver diseases

Mencin, A. M., Kluwe, J., & Schwabe, R. F. (2009) · Gut · doi:10.1136/gut.2008.156307 · Cited by 328 · see citing works

Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis

Guo, J., & Friedman, S. L. (2010) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-3-21 · Cited by 315 · see citing works

Inhibition of toll‐like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis

Abdollahi‐Roodsaz, S., Joosten, L. A. B., Roelofs, M. F., Radstake, T. R. D. J., Matera, G., Popa, C. D., van der Meer, J. W. M., Netea, M. G., & van den Berg, W. B. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22848 · Cited by 303 · see citing works

The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis

Lavelle, E. C., Murphy, C. H., O'Neill, L. A. J., & Creagh, E. M. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.124 · Cited by 291 · see citing works

Animal Models of Inflammatory Bowel Disease

Mizoguchi, A. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394596-9.00009-3 · Cited by 271 · see citing works

The role of pattern recognition receptors in intestinal inflammation

Fukata, M., & Arditi, M. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.13 · Cited by 255 · see citing works

New genes in inflammatory bowel disease: lessons for complex diseases?

Gaya, D. R., Russell, R. K., Nimmo, E. R., & Satsangi, J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68345-1 · Cited by 244 · see citing works

Protective effect of naringenin against experimental colitis via suppression of Toll-like receptor 4/NF-κB signalling

Dou, W., Zhang, J., Sun, A., Zhang, E., Ding, L., Mukherjee, S., Wei, X., Chou, G., Wang, Z., & Mani, S. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114512005594 · Cited by 237 · see citing works

Light-entrained and brain-tuned circadian circuits regulate ILC3s and gut homeostasis

Godinho‐Silva, C., Domingues, R. G., Rendas, M. A., Raposo, B., Ribeiro, H., da Silva, J. A., Vieira, A. I. S., Costa, R. M., Barbosa‐Morais, N. L., Carvalho, T., et al. (2019) · Nature · doi:10.1038/s41586-019-1579-3 · Cited by 220 · see citing works

Shift Towards Pro-inflammatory Intestinal Bacteria Aggravates Acute Murine Colitis via Toll-like Receptors 2 and 4

Heimesaat, M. M., Fischer, A., Siegmund, B., Kupz, A., Niebergall, J., Fuchs, D., Jahn, H.-K., Freudenberg, M., Loddenkemper, C., Batra, A., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000662 · Cited by 213 · see citing works

The role of TLR activation in inflammation

Sabroe, I., Parker, L. C., Dower, S., & Whyte, M. (2007) · The Journal of Pathology · doi:10.1002/path.2264 · Cited by 203 · see citing works

Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats

Bomfim, G. F., Eichler, R. A. D. S., Oliveira, M. A., Giachini, F. R. C., Akamine, E. H., Tostes, R. C., Fortes, Z. B., Webb, R. C., & de Carvalho, M. H. C. (2012) · Clinical Science · doi:10.1042/cs20110523 · Cited by 201 · see citing works

Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders

Leitner, G. R., Wenzel, T., Marshall, N., Gates, E. J., & Klegeris, A. (2019) · Expert opinion on therapeutic targets · doi:10.1080/14728222.2019.1676416 · Cited by 187 · see citing works

Regulation of interactions of Gram-negative bacterial endotoxins with mammalian cells

Gioannini, T. L., & Weiss, J. P. (2007) · Immunologic Research · doi:10.1007/s12026-007-0069-0 · Cited by 195 · see citing works

Fusobacterium nucleatum Induces Fetal Death in Mice via Stimulation of TLR4-Mediated Placental Inflammatory Response

Liu, H., Redline, R. W., & Han, Y. W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2501 · Cited by 181 · see citing works

Toll-Like Receptors in Liver Fibrosis: Cellular Crosstalk and Mechanisms

Yang, L., & Seki, E. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00138 · Cited by 175 · see citing works

Discovery and Development of Toll-Like Receptor 4 (TLR4) Antagonists: A New Paradigm for Treating Sepsis and Other Diseases

Leon, C. G., Tory, R., Jia, J. X., Sivak, O., & Wasan, K. M. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9571-x · Cited by 175 · see citing works

The Role of Carbohydrates in the Lipopolysaccharide (LPS)/Toll-Like Receptor 4 (TLR4) Signalling

Cochet, F., & Peri, F. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112318 · Cited by 168 · see citing works

How important are Toll‐like receptors for antimicrobial responses?

Carpenter, S., & O'Neill, L. A. J. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00965.x · Cited by 182 · see citing works

Opposing functions of IKKβ during acute and chronic intestinal inflammation

Eckmann, L., Nebelsiek, T., Fingerle, A. A., Dann, S. M., Mages, J., Lang, R., Robine, S., Kagnoff, M. F., Schmid, R. M., Karin, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808216105 · Cited by 166 · see citing works

Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli

Heimesaat, M. M., Fischer, A., Jahn, H.-K., Niebergall, J., Freudenberg, M. A., Blaut, M., Liesenfeld, O., Schumann, R. R., Göbel, U. B., & Bereswill, S. (2007) · Gut · doi:10.1136/gut.2006.104497 · Cited by 164 · see citing works

Pattern recognition receptors—Molecular orchestrators of inflammation in inflammatory bowel disease

Walsh, D. P., McCarthy, J., O’Driscoll, C. M., & Melgar, S. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.09.003 · Cited by 161 · see citing works

Lipopolysaccharide: Basic Biochemistry, Intracellular Signaling, and Physiological Impacts in the Gut

Rhee, S. H. (2014) · Intestinal Research · doi:10.5217/ir.2014.12.2.90 · Cited by 162 · see citing works

A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis

Ungaro, R., Fukata, M., Hsu, D., Hernandez, Y., Breglio, K., Chen, A., Xu, R., Sotolongo, J., Espana, C., Zaias, J., et al. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90496.2008 · Cited by 159 · see citing works

Toll-like Receptor 4 and Hepatic Fibrogenesis

Pradere, J.-P., Troeger, J., Dapito, D., Mencin, A., & Schwabe, R. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255353 · Cited by 158 · see citing works

Role of toll-like receptors in inflammatory bowel disease

Kordjazy, N., Haj‐Mirzaian, A., Haj‐Mirzaian, A., Rohani, M. M., Gelfand, E. W., Rezaei, N., & Abdolghaffari, A. H. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.11.017 · Cited by 155 · see citing works

No Longer an Innocent Bystander: Epithelial Toll-Like Receptor Signaling in the Development of Mucosal Inflammation

Gribar, S. C., Richardson, W. M., Sodhi, C. P., & Hackam, D. J. (2008) · Molecular Medicine · doi:10.2119/2008-00035.gribar · Cited by 155 · see citing works

Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis

van der Velden, W. J. F. M., Herbers, A. H. E., Netea, M. G., & Blijlevens, N. M. A. (2014) · British Journal of Haematology · doi:10.1111/bjh.13113 · Cited by 146 · see citing works

Inflammatory bowel disease, past, present and future: lessons from animal models

Mizoguchi, A., & Mizoguchi, E. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-007-2111-3 · Cited by 146 · see citing works

Lactobacillus amylovorus Inhibits the TLR4 Inflammatory Signaling Triggered by Enterotoxigenic Escherichia coli via Modulation of the Negative Regulators and Involvement of TLR2 in Intestinal Caco-2 Cells and Pig Explants

Finamore, A., Roselli, M., Imbinto, A., Seeboth, J., Oswald, I. P., & Mengheri, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094891 · Cited by 144 · see citing works

Molecular pathogenesis of inflammatory bowel disease: Genotypes, phenotypes and personalized medicine

Goyette, P., Labbé, C., Trinh, T. T., Xavier, R. J., & Rioux, J. D. (2007) · Annals of Medicine · doi:10.1080/07853890701197615 · Cited by 139 · see citing works

Discovery and Validation of a New Class of Small Molecule Toll-Like Receptor 4 (TLR4) Inhibitors

Neal, M. D., Jia, H., Eyer, B. R., Good, M. L., Guerriero, C. J., Sodhi, C. P., Afrazi, A., Prindle, T., Ma, C., Branca, M. F., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065779 · Cited by 137 · see citing works

Dietary Intake of Whole Strawberry Inhibited Colonic Inflammation in Dextran-Sulfate-Sodium-Treated Mice via Restoring Immune Homeostasis and Alleviating Gut Microbiota Dysbiosis

Han, Y., Song, M., Gu, M., Ren, D., Zhu, X., Cao, X., Li, F., Wang, W., Cai, X., Yuan, B., et al. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b05581 · Cited by 133 · see citing works

The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy

Lin, M. Y., Yiu, W. H., Li, R. X., Wu, H., Wong, D. W. L., Chan, L. Y. Y., Leung, J. C. K., Lai, K. N., & Tang, S. C. W. (2013) · Kidney International · doi:10.1038/ki.2013.11 · Cited by 131 · see citing works

The many faces of the flavivirus NS1 protein offer a multitude of options for inhibitor design

Watterson, D., Modhiran, N., & Young, P. R. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.02.014 · Cited by 128 · see citing works

Toll-like Receptors from the Perspective of Cancer Treatment

Javaid, N., & Choi, S. (2020) · Cancers · doi:10.3390/cancers12020297 · Cited by 128 · see citing works

Sensor molecules in intestinal innate immunity against bacterial infections

Eckmann, L. (2006) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000208458.38772.2a · Cited by 124 · see citing works

Paeoniflorin abrogates DSS-induced colitis via a TLR4-dependent pathway

Zhang, J., Dou, W., Zhang, E., Sun, A., Ding, L., Wei, X., Chou, G., Mani, S., & Wang, Z. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00465.2012 · Cited by 123 · see citing works

Toll-like receptor regulation of intestinal development and inflammation in the pathogenesis of necrotizing enterocolitis

Lü, P., Sodhi, C. P., & Hackam, D. J. (2013) · Pathophysiology · doi:10.1016/j.pathophys.2013.11.007 · Cited by 121 · see citing works

TLR4/MD-2 Monoclonal Antibody Therapy Affords Protection in Experimental Models of Septic Shock

Daubeuf, B., Mathison, J. C., Spiller, S., Hugues, S., Herren, S., Ferlin, W. G., Kosco‐Vilbois, M. H., Wagner, H., Kirschning, C. J., Ulevitch, R. J., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.6107 · Cited by 121 · see citing works

Antidepressants and inflammatory bowel disease: a systematic review.

Mikocka‐Walus, A. A., Turnbull, D. A., Moulding, N., Wilson, I. G., Andrews, J. M., & Holtmann, G. (2006) · Clinical Practice and Epidemiology in Mental Health · doi:10.1186/1745-0179-2-24 · Cited by 120 · see citing works

TLR2 mediates gap junctional intercellular communication through connexin-43 in intestinal epithelial barrier injury

Ey, B., Eyking, A., Gerken, G., Podolsky, D. K., & Cario, E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901619200 · Cited by 119 · see citing works

The Induction of Colitis and Ileitis in Mice Is Associated with Marked Increases in Intestinal Concentrations of Stimulants of TLRs 2, 4, and 5

Erridge, C., Duncan, S. H., Bereswill, S., & Heimesaat, M. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009125 · Cited by 119 · see citing works

Toll‐like receptor 4 mediates cross‐talk between peroxisome proliferator‐activated receptor γ and nuclear factor‐κB in macrophages

Necela, B. M., Su, W., & Thompson, E. A. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02849.x · Cited by 140 · see citing works

IL1β‐ and LPS‐induced serotonin secretion is increased in EC cells derived from Crohn’s disease

Kidd, M., Gustafsson, B. I., Drozdov, I., & Modlin, I. M. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01210.x · Cited by 130 · see citing works

Pretreatment With Toll-like Receptor 4 Antagonist Inhibits Lipopolysaccharide-Induced Preterm Uterine Contractility, Cytokines, and Prostaglandins in Rhesus Monkeys

Waldorf, K. M. A., Persing, D. H., Novy, M. J., Sadowsky, D. W., & Gravett, M. G. (2008) · Reproductive Sciences · doi:10.1177/1933719107310992 · Cited by 119 · see citing works

TLR4-induced IFN-γ production increases TLR2 sensitivity and drives Gram-negative sepsis in mice

Spiller, S., Elson, G., Ferstl, R., Dreher, S., Mueller, T., Freudenberg, M. A., Daubeuf, B., Wagner, H., & Kirschning, C. J. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071990 · Cited by 115 · see citing works

NF-κB and the intestine: Friend or foe?

Karrasch, T., & Jobin, C. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20243 · Cited by 110 · see citing works

METTL3 overexpression aggravates LPS-induced cellular inflammation in mouse intestinal epithelial cells and DSS-induced IBD in mice

Yang, L., Wu, G., Wu, Q., Peng, L., & Yuan, L. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-00849-1 · Cited by 110 · see citing works

“Dirty little secrets”—Endotoxin contamination of recombinant proteins

Wakelin, S. J., Sabroe, I., Gregory, C. D., Poxton, I. R., Forsythe, J. L. R., Garden, O. J., & Howie, S. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.04.007 · Cited by 109 · see citing works

Toll-Like Receptors in the Pathogenesis of Alcoholic Liver Disease

Petrášek, J., Mandrekar, P., & Szabó, G. (2010) · Gastroenterology Research and Practice · doi:10.1155/2010/710381 · Cited by 101 · see citing works

Hypertension augments cardiac Toll-like receptor 4 expression and activity

Eißler, R., Schmaderer, C., Rusai, K., Kühne, L., Sollinger, D., Lahmer, T., Witzke, O., Lutz, J., Heemann, U. W., & Baumann, M. (2011) · Hypertension Research · doi:10.1038/hr.2010.270 · Cited by 95 · see citing works

Novel critical role of Toll-like receptor 4 in lung ischemia-reperfusion injury and edema

Zanotti, G., Casiraghi, M., Abano, J. B., Tatreau, J. R., Sevala, M., Berlin, H., Smyth, S. S., Funkhouser, W. K., Burridge, K., Randell, S. H., et al. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90406.2008 · Cited by 95 · see citing works

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

Brenchley, J. M. (2006) · Retrovirology · doi:10.1186/1742-4690-3-s1-s98 · Cited by 98 · see citing works

Pattern Recognition Receptors in Cancer Progression and Metastasis

Pandey, S., Singh, S. P., Anang, V., Bhatt, A. N., Natarajan, K., & Dwarakanath, B. S. R. (2015) · Cancer Growth and Metastasis · doi:10.4137/cgm.s24314 · Cited by 95 · see citing works

Polysaccharides From Chrysanthemum morifolium Ramat Ameliorate Colitis Rats via Regulation of the Metabolic Profiling and NF-κ B/TLR4 and IL-6/JAK2/STAT3 Signaling Pathways

Tao, J., Duan, J., Zhang, W., Jiang, S., Guo, J., & Wei, D. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00746 · Cited by 91 · see citing works

Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation

Tam, J. S. Y., Coller, J. K., Hughes, P. A., Prestidge, C. A., & Bowen, J. M. (2021) · Indian Journal of Gastroenterology · doi:10.1007/s12664-020-01114-y · Cited by 91 · see citing works

Genetics of the innate immune response in inflammatory bowel disease

Limbergen, J. V., Russell, R. K., Nimmo, E. R., Ho, G., Arnott, I. D., Wilson, D. C., & Satsangi, J. (2006) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20096 · Cited by 88 · see citing works

Toll-Like Receptors in Liver Disease

Petrášek, J., Csák, T., & Szabó, G. (2012) · Advances in clinical chemistry · doi:10.1016/b978-0-12-405211-6.00006-1 · Cited by 85 · see citing works

Toll-like receptors: sensing and reacting to diabetic injury in the kidney

Lin, M., & Tang, S. C. W. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft446 · Cited by 86 · see citing works

Role of Toll-like receptors in liver health and disease

Broering, R., Lu, M., & Schlaak, J. (2011) · Clinical Science · doi:10.1042/cs20110065 · Cited by 83 · see citing works

Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease

LAVERNY, G., Penna, G., Vetrano, S., Correale, C., Nebuloni, M., Danese, S., & Adorini, L. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.03.006 · Cited by 81 · see citing works

TLR4 agonists as immunomodulatory agents

Alderson, M. R., McGowan, P., Baldridge, J. R., & Probst, P. (2006) · Journal of Endotoxin Research · doi:10.1179/096805106x118753 · Cited by 80 · see citing works

Toll-like receptors and innate immunity in gut homeostasis and pathology

Michelsen, K. S., & Arditi, M. (2007) · Current Opinion in Hematology · doi:10.1097/00062752-200701000-00010 · Cited by 80 · see citing works

Elevated lipopolysaccharide in the colon evokes intestinal inflammation, aggravated in immune modulator-impaired mice

Im, E., Riegler, F. M., Pothoulakis, C., & Rhee, S. H. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00120.2012 · Cited by 79 · see citing works

TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice

Lu, Z., Zhang, X., Li, Y., Jin, J., & Huang, Y. Q. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0338 · Cited by 78 · see citing works

Targeting Toll-like receptors: Emerging therapeutics for multiple sclerosis management

Gambuzza, M. E., Licata, N., Palella, E., Celi, D., Cuzzola, V. F., Italiano, D., Marino, S., & Bramanti, P. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.08.010 · Cited by 78 · see citing works

Synthetic TLR4-active Glycolipids as Vaccine Adjuvants and Stand-alone Immunotherapeutics

Johnson, D. A. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608783378882 · Cited by 77 · see citing works

Melatonin ameliorates TNBS-induced colitis in rats through the melatonin receptors: involvement of TLR4/MyD88/NF-κB signalling pathway

Chamanara, M., Rashidian, A., Mehr, S. E., Dehpour, A. R., Shirkohi, R., Akbarian, R., Abdollahi, A., & Rezayat, S. M. (2018) · Inflammopharmacology · doi:10.1007/s10787-018-0523-8 · Cited by 77 · see citing works

Extracellular S100A4 as a key player in fibrotic diseases

Li, Z., Li, Y., Liu, S., & Qin, Z. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15259 · Cited by 76 · see citing works

Association among genetic predisposition, gut microbiota, and host immune response in the etiopathogenesis of inflammatory bowel disease

Basso, P. J., Fonseca, M. T., Bonfá, G., Alves, V. B. F., Sales‐Campos, H., Nardini, V., & Cardoso, C. R. D. B. (2014) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20143932 · Cited by 75 · see citing works

Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis

Wang, F.-D., Zhou, J., & Chen, E. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.787748 · Cited by 74 · see citing works

Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness

Espinosa-Sánchez, A., Suárez-Martínez, E., Sánchez-Díaz, L., & Carnero, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01533 · Cited by 71 · see citing works

Novel Toll-like receptor-4 antagonist (+)-naloxone protects mice from inflammation-induced preterm birth

Chin, P. Y., Dorian, C. L., Hutchinson, M. R., Olson, D. M., Rice, K. C., Moldenhauer, L. M., & Robertson, S. A. (2016) · Scientific Reports · doi:10.1038/srep36112 · Cited by 69 · see citing works

Recent progress in the discovery of myeloid differentiation 2 (MD2) modulators for inflammatory diseases

Chen, L., Fu, W., Zheng, L., Wang, Y., & Liang, G. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.015 · Cited by 66 · see citing works

Bifidobacterium dentium N8 with potential probiotic characteristics prevents LPS-induced intestinal barrier injury by alleviating the inflammatory response and regulating the tight junction in Caco-2 cell monolayers

Zhao, L. M., Xie, Q., Evivie, S. E., Liu, D., Dong, J., Ping, L., Liu, F., Li, B., & Huo, G. (2021) · Food & Function · doi:10.1039/d1fo01164b · Cited by 66 · see citing works

Toll-like receptors as therapeutic targets in gastrointestinal diseases

Pimentel‐Nunes, P., Soares, J., Roncon‐Albuquerque, R., Dinis-Ribeiro, M. J., & Leite-Moreira, A. F. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728221003642027 · Cited by 66 · see citing works

The Effect of Toll-Like Receptors and Toll-Like Receptor Genetics in Human Disease

Garantziotis, S., Hollingsworth, J. W., Zaas, A. K., & Schwartz, D. A. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.59.061206.112455 · Cited by 63 · see citing works

Novel genetic markers in inflammatory bowel disease

Rodríguez-Bores, L. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i42.5560 · Cited by 61 · see citing works

Bench-to-bedside review: Sepsis, severe sepsis and septic shock – does the nature of the infecting organism matter?

Gao, H., Evans, T. W., & Finney, S. J. (2008) · Critical Care · doi:10.1186/cc6862 · Cited by 59 · see citing works

NSAID-induced intestinal damage: are luminal bacteria the therapeutic target?

Scarpignato, C. (2008) · Gut · doi:10.1136/gut.2007.134502 · Cited by 59 · see citing works

Lactobacillus casei prevents the development of dextran sulphate sodium-induced colitis in Toll-like receptor 4 mutant mice

Chung, Y. W., Choi, J. H., Oh, T.-Y., Eun, C. S., & Han, D. S. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03549.x · Cited by 57 · see citing works

Loss of TLR2 Worsens Spontaneous Colitis in MDR1A Deficiency through Commensally Induced Pyroptosis

Ey, B., Eyking, A., Klepak, M., Salzman, N. H., Göthert, J. R., Rünzi, M., Schmid, K. W., Gerken, G., Podolsky, D. K., & Cario, E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201592 · Cited by 56 · see citing works

Non-viral delivery of nuclear factor-κB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis

Vry, C. G. D., Prasad, S., Kömüves, L. G., Lorenzana, C., Parham, C. L., Le, T., Adda, S., Hoffman, J., Kahoud, N., Garlapati, R., et al. (2006) · Gut · doi:10.1136/gut.2006.096487 · Cited by 55 · see citing works

Inflammatory auto-immune diseases of the intestine and their management by natural bioactive compounds

Menyiy, N. E., Allam, A. E., Aboulaghras, S., Jaouadi, I., Bakrim, S., Omari, N. E., Shariati, M. A., Мифтахутдинов, А. В., Wilairatana, P., Mubarak, M. S., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113158 · Cited by 50 · see citing works

Toll-like receptor 4: A promising crossroads in the diagnosis and treatment of several pathologies

García, M. M., Goicoechea, C., Álvarez, M. M., & Pascual, D. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.172975 · Cited by 50 · see citing works

Lipid Core Peptide System for Gene, Drug, and Vaccine Delivery

Zhong, W., Skwarczyński, M., & Tóth, I. (2009) · Australian Journal of Chemistry · doi:10.1071/ch09149 · Cited by 48 · see citing works

Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation

Tam, J. S. Y., Coller, J. K., Hughes, P. A., Prestidge, C. A., & Bowen, J. M. (2021) · Indian Journal of Gastroenterology · doi:10.1007/s12664-020-01114-y · Cited by 91 · see citing works

A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis

Ungaro, R., Fukata, M., Hsu, D., Hernandez, Y., Breglio, K., Chen, A., Xu, R., Sotolongo, J., Espana, C., Zaias, J., et al. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90496.2008 · Cited by 159 · see citing works

Blockade of CXCL12/CXCR4 Axis Ameliorates Murine Experimental Colitis

Mikami, S., Nakase, H., Yamamoto, S., Takeda, Y., Yoshino, T., Kasahara, K., Ueno, S., Uza, N., Oishi, S., Fujii, N., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141085 · Cited by 106 · see citing works

Oral administration of Lactococcus lactis expressing recombinant 15-lipoxygenase-1 (15 LOX-1) modulates chemically induced colitis in mice

Carvalho, R. D. D. O. (2016) · Medical Research Archives · doi:10.18103/mra.v4i7.612 · Cited by 10 · see citing works

Effect of chemical modulation of toll-like receptor 4 in an animal model of ulcerative colitis

Facchini, F. A., Fusco, D. D., Barresi, S., Luraghi, A., Minotti, A., Granucci, F., Monteleone, G., Peri, F., & Monteleone, I. (2020) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-019-02799-7 · Cited by 19 · see citing works